Hence, it was reported that folate–miR-34a did not inhibit PC growth, in accordance with additional studies that have indicated low FOLR1 expression in PC; thus, the strategy of blocking the folate receptor via ligand-conjugated miR-34 is not appropriate in PC. Here, FOLR1 is linked to pachyonychia congenita.